Clinical trial
Cluster Randomized Controlled Trial of Patient and Provider Decision Support to Increase Chemoprevention Informed Choice Among Women With Atypical Hyperplasia or Lobular Carcinoma In Situ - Making Informed Choices on Incorporating Chemoprevention Into Care (MiChoice)
NCT04496739 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cluster Randomized Controlled Trial of Patient and Provider Decision Support to Increase Chemoprevention Informed Choice Among Women With Atypical Hyperplasia or Lobular Carcinoma In Situ - Making Informed Choices on Incorporating Chemoprevention Into Care (MiChoice)
- Lead sponsor
- SWOG Cancer Research Network
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 23, 2020
- Completion date
- June 1, 2028
- Enrollment
- 412 (actual)
- Sites
- 97
Conditions
As the registry lists them; a condition with its own page is linked.
atypical hyperplasia of the breast, lobular breast carcinoma in situ, pleomorphic lobular breast carcinoma in situ